4.7 Review

Hormone-like fibroblast growth factors and metabolic regulation

期刊

出版社

ELSEVIER
DOI: 10.1016/j.bbadis.2011.04.002

关键词

FGF19; FGF21; FGF23; Klotho; beta Klotho; Metabolic regulation

向作者/读者索取更多资源

The family of fibroblast growth factors (FGFs) consisting now of 22 members is generally considered to control a wide range of biological functions such as development, differentiation and survival. However, research during the past decade provided substantial evidence that a so called hormone-like subgroup of FGFs, comprised of FGF19, FGF21 and FGF23, is involved in the regulation of diverse metabolic pathways to control glucose, lipid, bile acid, phosphate and vitamin D metabolism. The unique properties of these FGFs include predominant production of the factors in selective tissues, their abundance in the blood due to the lack of extracellular heparin-mediated sequestration, and highly specific tissue-targeted action via engagement of their respective co-receptors. The important metabolic context of FGF19, FGF21, and FGF23 actions has revealed important novel roles for FGFs and provided significant means to explore an opportunity for therapeutic targeting of these factors and their corresponding pathways. (C) 2011 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Central Fibroblast Growth Factor 21 Browns White Fat via Sympathetic Action in Male Mice

Nicholas Douris, Darko M. Stevanovic, Ffolliott M. Fisher, Theodore I. Cisu, Melissa J. Chee, Ngoc L. Nguyen, Eleen Zarebidaki, Andrew C. Adams, Alexei Kharitonenkov, Jeffrey S. Flier, Timothy J. Bartness, Eleftheria Maratos-Flier

ENDOCRINOLOGY (2015)

Article Endocrinology & Metabolism

Naringenin Prevents Obesity, Hepatic Steatosis, and Glucose Intolerance in Male Mice Independent of Fibroblast Growth Factor 21

Julia M. Assini, Erin E. Mulvihill, Amy C. Burke, Brian G. Sutherland, Dawn E. Telford, Sanjiv S. Chhoker, Cynthia G. Sawyez, Maria Drangova, Andrew C. Adams, Alexei Kharitonenkov, Christopher L. Pin, Murray W. Huff

ENDOCRINOLOGY (2015)

Correction Medicine, Research & Experimental

Interplay between FGF21 and insulin action in the liver regulates metabolism (vol 124, pg 515, 2014)

Brice Emanuelli, Sara G. Vienberg, Graham Smyth, Christine Cheng, Kristin I. Stanford, Manimozhiyan Arumugam, Mervyn D. Michael, Andrew C. Adams, Alexei Kharitonenkov, C. Ronald Kahn

JOURNAL OF CLINICAL INVESTIGATION (2015)

Article Endocrinology & Metabolism

Dual effects of fibroblast growth factor 21 on hepatic energy metabolism

Ricardo J. Samms, Michelle Murphy, Maxine J. Fowler, Scott Cooper, Paul Emmerson, Tamer Coskun, Andrew C. Adams, Alexei Kharitonenkov, Francis J. P. Ebling, Kostas Tsintzas

JOURNAL OF ENDOCRINOLOGY (2015)

Review Endocrinology & Metabolism

FGF21 Revolutions: Recent Advances Illuminating FGF21 Biology and Medicinal Properties

Alexei Kharitonenkov, Richard DiMarchi

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)

Article Endocrinology & Metabolism

Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity

Ricardo J. Samms, Christine C. Cheng, Alexei Kharitonenkov, Ruth E. Gimeno, Andrew C. Adams

ENDOCRINOLOGY (2016)

Article Biochemistry & Molecular Biology

The Nuclear Receptor Rev-erbα Regulates Adipose Tissue-specific FGF21 Signaling

Jennifer Jager, Fenfen Wang, Bin Fang, Hee-Woon Lim, Lindsey C. Peed, David J. Steger, Kyoung-Jae Won, Alexei Kharitonenkov, Andrew C. Adams, Mitchell A. Lazar

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Review Medicine, General & Internal

Fibroblast growth factor 21 night watch: advances and uncertainties in the field

A. Kharitonenkov, R. DiMarchi

JOURNAL OF INTERNAL MEDICINE (2017)

Article Endocrinology & Metabolism

Fibroblast activation protein (FAP) as a novel metabolic target

Miguel Angel Sanchez-Garrido, Kirk M. Habegger, Christoffer Clemmensen, Cassie Holleman, Timo D. Mueller, Diego Perez-Tilve, Pengyun Li, Archita S. Agrawal, Brian Finan, Daniel J. Drucker, Matthias H. Tschoep, Richard D. DiMarchi, Alexei Kharitonenkov

MOLECULAR METABOLISM (2016)

Article Nutrition & Dietetics

Cholic Acid Supplementation of a High-Fat Obesogenic Diet Suppresses Hepatic Triacylglycerol Accumulation in Mice via a Fibroblast Growth Factor 21-Dependent Mechanism

Siri M. Ippagunta, Alexei Kharitonenkov, Andrew C. Adams, F. Bradley Hillgartner

JOURNAL OF NUTRITION (2018)

Article Endocrinology & Metabolism

Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity

Archita Agrawal, Sebastian Parlee, Diego Perez-Tilve, Pengyun Li, Jia Pan, Piotr A. Mroz, Ann Maria Kruse Hansen, Birgitte Andersen, Brian Finan, Alexei Kharitonenkov, Richard D. DiMarchi

MOLECULAR METABOLISM (2018)

Editorial Material Endocrinology & Metabolism

Another Kid on the Block: Long-acting FGF21 Analogue to Treat Dyslipidemia and Fatty Liver

Ranyao Yang, Aimin Xu, Alexei Kharitonenkov

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Meeting Abstract Endocrinology & Metabolism

Glp-1/gdf15 dual agonist to treat obesity and hyperglycaemia in mice and non-human primates

Y. Y. Zhang, A. Kharitonenkov, X. Y. Zhao, X. N. Dong, Y. Y. Zhang, H. X. Zou, Y. G. Jin, W. Guo, P. Zhai, X. Chen

DIABETOLOGIA (2022)

Article Chemistry, Medicinal

Optimization of Peptide Inhibitors of ß-Klotho as Antagonists of Fibroblast Growth Factors 19 and 21

Jia Pan, Sebastian D. Parlee, Florence M. Brunel, Pengyun Li, Wei Lu, Diego Perez-Tilve, Fa Liu, Brian Finan, Alexei Kharitonenkov, Richard D. DiMarchi

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)

Review Biochemistry & Molecular Biology

A mitochondrial nexus in major depressive disorder: Integration with the psycho-immune-neuroendocrine network

M. T. Ciubuc-Batcu, N. J. C. Stapelberg, J. P. Headrick, G. M. C. Renshaw

Summary: The nervous system relies on mitochondria, and impaired mitochondrial function is associated with major depressive disorder. Modulating mitochondrial function may be a therapeutic target for treating MDD.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Correction Biochemistry & Molecular Biology

Diminishing acetyl-CoA carboxylase 1 attenuates CCA migration via AMPK-NF-κB-snail axis (vol 1869, 166694, 2023)

Saowaluk Saisomboon, Ryusho Kariya, Piyanard Boonnate, Kanlayanee Sawanyawisuth, Ubon Cha'on, Vor Luvira, Yaovalux Chamgramol, Chawalit Pairojkul, Wunchana Seubwai, Atit Silsirivanit, Sopit Wongkham, Seiji Okada, Sarawut Jitrapakdee, Kulthida Vaeteewoottacharn

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Humanin ameliorates TBI-related cognitive impairment by attenuating mitochondrial dysfunction and inflammation

Pavan Thapak, Zhe Ying, Victoria Palafox-Sanchez, Guanglin Zhang, Xia Yang, Fernando Gomez-Pinilla

Summary: Traumatic brain injury (TBI) impairs cellular energy demand, compromising neuronal function and plasticity. This study demonstrates that the mitochondrial activator humanin (HN) can counteract the reduction in mitochondrial bioenergetics caused by TBI, restore memory function and synaptic protein levels, and suppress inflammation and astrocyte proliferation. HN plays an integral role in normalizing fundamental aspects of TBI pathology.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

The amyloid-β peptide: Guilty as charged?

M. Paul Murphy, Valeria A. Buzinova, Carrie E. Johnson

Summary: Progress has been made in the treatment of Alzheimer's disease through the development of anti-A beta therapeutics, which have shown modest efficacy in slowing the progression of the disease. However, the puzzling issue remains as to why completely removing A beta does not fully stop the disease.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Review Biochemistry & Molecular Biology

Reactive oxygen species in colorectal cancer adjuvant therapies

Yang Zhang, Mengqiu Hao, Xuyang Yang, Su Zhang, Junhong Han, Ziqiang Wang, Hai-Ning Chen

Summary: Colorectal cancer often requires adjuvant therapies to reduce tumor burden, and the efficacy of these therapies is significantly influenced by reactive oxygen species (ROS). ROS-mediated colorectal cancer adjuvant therapies involve multiple mechanisms, and preliminary clinical trials have shown the potential of ROS-manipulating therapy in enhancing treatment outcomes.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

GK921, a transglutaminase inhibitor, strengthens the antitumor effect of cisplatin on pancreatic cancer cells by inhibiting epithelial-to-mesenchymal transition

Mengxin Li, Xuanzhong Wang, Xuyang Chen, Jinghui Hong, Ye Du, Dong Song

Summary: Pancreatic adenocarcinoma (PAAD) is a common digestive malignant tumor with limited treatment options. This study demonstrates that TGM2 may serve as a marker for treatment and prognosis in pancreatic cancer patients. Co-treatment of low dose cisplatin (DDP) and the TGM2 inhibitor GK921 effectively inhibits PAAD cell viability and proliferation in vitro and in vivo, by inhibiting epithelial-to-mesenchymal transition (EMT) induced by TGM2 and enhancing cell cycle arrest and apoptosis caused by DDP. These findings suggest that the combination of GK921 and DDP holds promise as a treatment for PAAD patients.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Small extracellular vesicles-mediated cellular interactions between tumor cells and tumor-associated macrophages: Implication for immunotherapy

Liaoran Niu, Qi Wang, Fan Feng, Wanli Yang, Zhenyu Xie, Gaozan Zheng, Wei Zhou, Lili Duan, Kunli Du, Yiding Li, Ye Tian, Junfeng Chen, Qibin Xie, Aqiang Fan, Hanjun Dan, Jinqiang Liu, Daiming Fan, Liu Hong, Jian Zhang, Jianyong Zheng

Summary: This review provides a comprehensive summary of the interaction between cancer cells and macrophages in the tumor microenvironment, and discusses the role of small extracellular vesicles (sEVs) in this process. It also explores the various effects of macrophage-secreted sEVs on tumor malignant transformation, and addresses the therapeutic advancements and challenges associated with these vesicles.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Protective effects of SSRI, Citalopram in mutant APP and mutant Tau expressed dorsal raphe neurons in Alzheimer's disease

Neha Sawant, Sudhir Kshirsagar, P. Hemachandra Reddy, Arubala P. Reddy

Summary: Depression is a common neuropsychiatric comorbidity in Alzheimer's disease (AD) and other Tauopathies. Selective serotonin reuptake inhibitor (SSRI) treatment, such as Citalopram, not only has anti-depressive and anxiolytic effects, but also helps improve neurogenesis, reduce amyloid burden & Tau pathologies, and neuroinflammation in AD. In this study, Citalopram was found to reduce pathologically pTau level, increase synaptic gene expression and cytoskeletal structure, as well as improve cell survival, mitochondrial respiration, and mitochondrial morphology in cells expressing mutant APP and Tau. These findings suggest that Citalopram could be a promising therapeutic drug for treating depression and AD.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Dynamic chromatin accessibility landscapes of osteoblast differentiation and mineralization

Yueqi Chen, Jiulin Tan, Chuan Yang, Zhiguo Ling, Jianzhong Xu, Dong Sun, Fei Luo

Summary: Bone is a self-healing organ that undergoes continuous regeneration through the cooperation of osteoclasts and osteoblasts. This study used ATAC-seq and RNA-Seq techniques to investigate the chromatin accessibility and transcriptomic landscape of osteoblast differentiation and mineralization. The results showed that global chromatin accessibility was extensively improved during osteoblastogenesis. Additionally, several transcription factors including MEF2A, PRRX1, Shox2, and HOXB13 were found to modulate the promoter accessibility of target genes during osteoblast differentiation.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Deficiency of BCAT2-mediated branched-chain amino acid catabolism promotes colorectal cancer development

Zi-Ran Kang, Shanshan Jiang, Ji-Xuan Han, Yaqi Gao, Yile Xie, Jinxian Chen, Qiang Liu, Jun Yu, Xin Zhao, Jie Hong, Haoyan Chen, Ying-Xuan Chen, Huimin Chen, Jing-Yuan Fang

Summary: The study demonstrates that BCAA metabolism is involved in the development of colorectal cancer (CRC). BCAT2 deficiency promotes CRC progression by inhibiting BCAA metabolism and chronically activating the mTORC1 pathway.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Alleviation of experimental autoimmune encephalomyelitis by transferring low RelB expression tolerogenic dendritic cells

Chao Zheng, Lingling Liu, Caiyun Liu, Fengna Chu, Yue Lang, Shan Liu, Yan Mi, Jie Zhu, Tao Jin

Summary: Inducing tolerogenic dendritic cells (tDCs) with low RelB expression could effectively alleviate symptoms and reduce immune cell infiltration and demyelination in experimental autoimmune encephalomyelitis (EAE) mouse model.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Soluble adenylyl cyclase, the cell-autonomous member of the family

Hang Lam Li, Simei Go, Jung-Chin Chang, Arthur Verhoeven, Ronald Oude Elferink

Summary: This review highlights the distinct characteristics and crucial role of soluble adenylyl cyclase (sAC) in cellular processes, as well as recent significant advancements in the field of sAC research.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Resistance to apoptosis in complicated Crohn's disease: Relevance in ileal fibrosis

M. Seco-Cervera, D. Ortiz-Masia, D. C. Macias-Ceja, S. Coll, L. Gisbert-Ferrandiz, J. Cosin-Roger, C. Bauset, M. Ortega, B. Heras-Moran, F. Navarro-Vicente, M. Millan, J. V. Esplugues, S. Calatayud, M. D. Barrachina

Summary: The study revealed the presence of resistance to apoptosis in complicated ileal Crohn's disease, with PDGFB inducing an ETS1-mediated resistance to apoptosis associated with an inflammatory and fibrogenic pattern of expression in intestinal fibroblasts. Potential targets against ileal fibrosis include PDGFRB, IL1R1, or MCL1.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Review Biochemistry & Molecular Biology

Arming oncolytic viruses with bispecific T cell engagers: The evolution and current status

Yunmeng Wang, Ping Cheng

Summary: Oncolytic viruses (OVs) are emerging as therapeutically relevant anticancer agents, especially when combined with genetically modified bispecific T cell engagers (BiTEs). This combination strategy can overcome the limitations of BiTEs alone and provide targeted cytotoxicity to solid tumors.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

Article Biochemistry & Molecular Biology

Impaired digestive function of sucrase-isomaltase in a complex with the Greenlandic sucrase-isomaltase variant

Stephanie Tannous, Hassan Y. Naim

Summary: Congenital sucrase-isomaltase deficiency (CSID) is an autosomal recessive disorder caused by variants in the SI gene. A frameshift mutation called c.273_274delAG (p.Gly92Leufs*8) has been identified in CSID patients in Greenlandic population, which leads to loss of digestive function of SI. Surprisingly, the truncated mutant can still be located on the cell surface and interacts with wild type SI, negatively affecting its enzymatic function. Furthermore, heterozygote carriers of this mutation may also exhibit CSID symptoms.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)